Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Kits de Ensayo > Kits de Ensayo ADA

Ifabotuzumab ELISA Kit (DB681018)

Ifabotuzumab ELISA Kit
Ifabotuzumab ELISA Kit
Precio(USD):
Especificación:
  • 96T
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoDB681018
Descripción
Ifabotuzumab ELISA Kit (DB681018) — Quantitative sandwich ELISA for Ifabotuzumab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml.
Highlights
  • ●Sandwich Format — High specificity, reliable quantification.
  • ●High Sensitivity — Optimized for low-abundance target detection.
  • ●Ready-to-Use — Complete kit with pre-coated plates included.
Tipo de muestraPlasma, Serum
Sensibilidad0.156 μg/ml
Rango0.31-5 μg/mL
Número de acceso P29320
Aplicaciones ELISA
Método de detección Colorimetric
Tipo de ensayo Quantitative
Recuperación 80-120%
Envío 2-8 ℃
Estabilidad y almacenamiento The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Especificaciones

Ifabotuzumab

Nombres alternativosFibatuzumab, KB-004, , 1234137-51-9
Fondo

Ephrin type-A receptor 3 (Ifabotuzumab) is a ~110 kDa protein. Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Highly promiscuous for ephrin-A ligands it binds preferentially EFNA5. Upon activation by EFNA5 regulates cell-cell adhesion, cytoskeletal organization and cell migration. Also activated by EFNA1, inhibiting epithelial-to-mesenchymal transition of cardiac cells and playing a role in heart development.

1. Lawrenson, ID. et al. (2002) Journal of cell science 115, 1059-72. PMID: 11870224
2. Sharfe, N. et al. (2003) Journal of immunology (Baltimore, Md. : 1950) 170, 6024-32. PMID: 12794130
Nota For Research Use Only.
Imágenes
  • Ifabotuzumab ELISA Kit

    Standard Curve

    Standard Curve of Ifabotuzumab ELISA Kit

Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores